Prohibition Partners · Free weekly briefing
International Cannabis Weekly
The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.
349
7 regions32 stories3 publishers13 countries
Top story
Biden confirms cannabis will be rescheduled from Schedule I to Schedule III
This ‘tectonic shift’ in policy has been widely expected since April 30 when reports surfaced that the Drug Enforcement Administration (DEA) would support the move.
USRegulationlink no longer available
- 01
Head of New York's OCM forced to resign over adult-use rollout
USRegulationlink no longer available
- 02
German minister signals end of 'senseless' intoxication clause
DERegulationlink no longer available
Europe
7 stories- Czech Republic's revolutionary legislation to regulate psychoactive substances such as HHC clears first hurdle
CZPsychedelicslink no longer available
- Zurich Executive Summit: Unveiling future of cannabis pharmaceutical collaboration
CHEvents & Industrylink no longer available
- Oxford Cannabinoid Technologies delisting from London Stock Exchange may not be last
GBBusiness & Investmentlink no longer available
- SOMAÍ to exclusively cultivate, manufacture and distribute Cookies products in Europe
EUBusiness & Investmentlink no longer available
- Celadon Pharmaceuticals releases full-year 2023 results with revenues over three times greater than 2022
Business & Investmentlink no longer available
- Medical cannabis improves quality of life in MS and osteoarthritis, UK research suggests
GBHealth & Sciencelink no longer available
- European cannabis stocks report
Business of CannabisBusiness & Investment
United States
6 stories- Wisconsin governor hopeful cannabis will be legalised if Democrats win control
USAdult-uselink no longer available
- Nebraska medical cannabis ballot campaign meets key requirement with valid petitions
USMedicallink no longer available
- Cresco Labs races to meet Ohio's adult-use cannabis demand amid supply chain concerns
USAdult-uselink no longer available
- House Committee proposes ending cannabis consumption testing for military recruits
USRegulationlink no longer available
- Florida cannabis campaign releases ads to build support for legalisation ballot initiative
USAdult-uselink no longer available
- US congressional researchers state DEA will 'likely' reschedule cannabis
USRegulationlink no longer available
Canada
6 stories- Organigram reports boost in recreational revenues but significant profit decline
CABusiness & Investmentlink no longer available
- SNDL reports first profitable quarter for cannabis production, increases retail losses
CABusiness & Investmentlink no longer available
- Motif Labs eyes US market as CEO outlines future vision
CAUSBusiness & Investmentlink no longer available
- SNDL and Nova Cannabis complete assignment of Dutch Love stores
CABusiness & Investmentlink no longer available
- Health Canada recalls Organigram dried flower product due to incorrect THC labelling
CARegulationlink no longer available
- Canadian cannabis stocks rally as US takes step toward rescheduling cannabis
cp24.comCAUSBusiness & Investment
LATAM & Caribbean
4 stories- Only 14.6 of 9,977 hectares licensed for cannabis cultivation in Colombia being used
COBusiness & Investmentlink no longer available
- Anvisa approves report assessing regulatory landscape for medical cannabis in Brazil
BRRegulationlink no longer available
- Brazilian government set to allocate millions to drug policy programmes
BRRegulationlink no longer available
- Colombian government to spend five billion Colombian pesos on promoting cannabis production
COBusiness & Investmentlink no longer available
Africa & Middle East
2 stories- Emerging medical cannabis market challenges identified in Lesotho
jcannabisresearch.biomedcentral.comLSMedical
- Cannabis legalisation could boost Malawi economy as tobacco farms decline
MWRegulationlink no longer available
APAC
2 stories- Thai cannabis groups urge government to reconsider re-criminalisation plan
THRegulationlink no longer available
- Pakistan to pursue medical cannabis and hemp for economic growth
PKRegulationlink no longer available
Oceania
2 stories- Cann Group secures additional AU$5 million in debt funding
AUBusiness & Investmentlink no longer available
- Avecho doses first patient in phase III CBD soft-gel trial for insomnia
AUHealth & Sciencelink no longer available
Never miss an issue
International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.
From the research library
Global Medical Cannabis Market Review
14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.
From £1,265
View report